Larimar Therapeutics, Inc. (LRMR) vs Niagen Bioscience, Inc. (NAGE)
- Larimar Therapeutics, Inc. LRMR 1.99 0.00%
- Niagen Bioscience, Inc. NAGE 2.49 −3.49%
Larimar Therapeutics, Inc. and Niagen Bioscience, Inc. are both Biotechnology companies. Larimar Therapeutics, Inc. and Niagen Bioscience, Inc. are of similar size ($206.7M and $204.2M). Larimar Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 12.5×. Niagen Bioscience, Inc. has the higher net margin (12.4% vs 0.00%) and the higher return on invested capital (42.0% vs 0.00%). Across the 13 metrics below, Niagen Bioscience, Inc. leads on 12 and Larimar Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | LRMR | NAGE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 64.24% | 65.16% |
| Operating margin | 0.00% | 8.21% | 0.00% |
| Net margin | 0.00% | 12.39% | 0.00% |
| Free cash flow margin | 0.00% | 8.89% | 0.00% |
| Return on equity | (138.41%) | 21.80% | (56.36%) |
| Return on assets | (108.53%) | 16.14% | (48.04%) |
| Return on invested capital | 0.00% | 41.95% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack